# GlaxoSmithKline Biologicals SA – FDA Inspection, Jun 24, 2019

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/c59f4d26-ddd7-4e65-b71c-2b9e086c0932
Source feed: FDA_Inspections

> FDA inspection 1099401 of GlaxoSmithKline Biologicals SA, June 24, 2019. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099401
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2019-06-24
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1305486 - 2026-02-27](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a73f4473-48f2-4d60-ada1-1284eeb61f46)
- FDA Inspection 1214970 - 2023-06-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7)
- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/shuang-tang/092f82be-f1d9-4c9d-a132-f1f653d47ead)
- [Issuing Officer](https://www.keypedia.com/people/susan-m-jackson/2a4e01d1-8761-4d40-b493-69a4163473bb)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/9a234513-4162-49b8-b149-5c1be5aa9090

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8